U01DA053893
Cooperative Agreement
Overview
Grant Description
Wastewater detection of COVID-19 - When faced with a pandemic such as SARS-Coronavirus-2 (SAR-CoV-2), the virus responsible for COVID-19, timely risk assessment and action are required to prevent public health impacts to entire communities. Because infected individuals may not have access to testing or may be asymptomatic and contraction can mean death, a proactive approach to detect the virus is needed to develop public health strategy to mitigate virus spread.
Recent studies have detected SAR-CoV-2 genetic material in sewage and demonstrate a positive correlation between the concentration of viral markers and reported cases1-5. The Coronavirus Sewershed Surveillance Project (CSSP) is a collaborative effort to monitor sewersheds for genetic indicators of COVID-19 in wastewater to provide additional, population-level information about virus circulation that is not captured by clinical testing.
Untreated wastewater (influent) samples are screened weekly from select sewersheds and targeted micro-sewersheds for detection and "true" prevalence. Congregate facilities provide unique opportunities for study because they are controlled populations where the precise number and timing of infections can be defined. Our team will utilize detailed monitoring of congregate facilities to define the precise per patient contribution and longevity of SAR-CoV-2 RNA to wastewater by 1) increasing the number of facilities tested, 2) altering the frequency at which samples are collected, and 3) comparing sewershed data collected to clinical patient case data.
Although SAR-CoV-2 contribution/patient varies among communities, there have been clear outlier communities that produce little or no genetic material in the wastewater despite the presence of known outbreaks. The reason for this lost signal is not known, so our team will define factors that contribute to SAR-CoV-2 signal suppression in wastewater by 1) defining the physical nature of the genetic material in the sewershed to better understand the types of factors that could suppress signal, 2) expanding testing within sewersheds with suppressed signal as well as from additional facilities with similar population and industry demographics as those with suppressed signal to narrow the sources of signal suppression, 3) performing exhaustive chemical characterization comparing wastewater from locations that are suppressed to those that are not to identify candidate compounds that could be causing suppression, and 4) obtaining or generating candidate inhibitors and test their ability to suppress signal from viral genetic material in a controlled experimental setting.
Recent studies have detected SAR-CoV-2 genetic material in sewage and demonstrate a positive correlation between the concentration of viral markers and reported cases1-5. The Coronavirus Sewershed Surveillance Project (CSSP) is a collaborative effort to monitor sewersheds for genetic indicators of COVID-19 in wastewater to provide additional, population-level information about virus circulation that is not captured by clinical testing.
Untreated wastewater (influent) samples are screened weekly from select sewersheds and targeted micro-sewersheds for detection and "true" prevalence. Congregate facilities provide unique opportunities for study because they are controlled populations where the precise number and timing of infections can be defined. Our team will utilize detailed monitoring of congregate facilities to define the precise per patient contribution and longevity of SAR-CoV-2 RNA to wastewater by 1) increasing the number of facilities tested, 2) altering the frequency at which samples are collected, and 3) comparing sewershed data collected to clinical patient case data.
Although SAR-CoV-2 contribution/patient varies among communities, there have been clear outlier communities that produce little or no genetic material in the wastewater despite the presence of known outbreaks. The reason for this lost signal is not known, so our team will define factors that contribute to SAR-CoV-2 signal suppression in wastewater by 1) defining the physical nature of the genetic material in the sewershed to better understand the types of factors that could suppress signal, 2) expanding testing within sewersheds with suppressed signal as well as from additional facilities with similar population and industry demographics as those with suppressed signal to narrow the sources of signal suppression, 3) performing exhaustive chemical characterization comparing wastewater from locations that are suppressed to those that are not to identify candidate compounds that could be causing suppression, and 4) obtaining or generating candidate inhibitors and test their ability to suppress signal from viral genetic material in a controlled experimental setting.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Jefferson City,
Missouri
651095796
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been shortened from 05/31/23 to 12/31/22 and the total obligations have increased 98% from $2,000,004 to $3,962,917.
Missouri Department Of Health And Senior Services was awarded
Wastewater Detection of COVID-19
Cooperative Agreement U01DA053893
worth $3,962,917
from the National Institute of Allergy and Infectious Diseases in January 2020 with work to be completed primarily in Jefferson City Missouri United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed).
Status
(Complete)
Last Modified 10/21/24
Period of Performance
1/1/21
Start Date
12/31/22
End Date
Funding Split
$4.0M
Federal Obligation
$0.0
Non-Federal Obligation
$4.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01DA053893
Transaction History
Modifications to U01DA053893
Additional Detail
Award ID FAIN
U01DA053893
SAI Number
U01DA053893-1172022476
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75N600 NIH NATIONAL INSITUTE ON DRUG ABUSE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
UETLXV8NG8F4
Awardee CAGE
3A4D6
Performance District
MO-03
Senators
Joshua Hawley
Eric Schmitt
Eric Schmitt
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services (075-0140) | Health care services | Grants, subsidies, and contributions (41.0) | $1,962,927 | 100% |
Modified: 10/21/24